» Articles » PMID: 21395215

Occurrence of Phthalate Metabolites in Human Urine from Several Asian Countries

Overview
Date 2011 Mar 15
PMID 21395215
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The occurrence of 14 phthalate metabolites was found in human urine samples collected from seven Asian countries: China, India, Japan, Korea, Kuwait, Malaysia, and Vietnam. Phthalate metabolites were found in all samples, indicating widespread exposure of humans to phthalates in these Asian countries. The highest total (the sum of 14 phthalates) phthalate metabolite concentrations were found in samples collected from Kuwait (median: 1050 ng/mL), followed in decreasing order by samples from India (389 ng/mL), China (234 ng/mL), Vietnam (133 ng/mL), Japan (120 ng/mL), Korea (117 ng/mL), and Malaysia (94.9 ng/mL). The creatinine-adjusted median concentrations of total phthalates for urine samples from Kuwait, India, China, Vietnam, Japan, Korea, and Malaysia were 692, 506, 289, 119, 103, 104, and 169 μg/g creatinine, respectively. Monomethyl phthalate (mMP), monoethyl phthalate (mEP), mono (2-isobutyl phthalate) (miBP), mono-n-butyl phthalate (mBP), and metabolites of di-(2-ethylhexyl) phthalate (DEHP) were the dominant compounds, collectively accounting for >95% of the total concentrations in the samples from the seven countries. The profiles of urinary phthalate metabolite concentrations varied among the samples collected from the seven countries. Urine samples from Kuwait contained the highest concentrations of mEP (median: 391 ng/mL), mBP (94.1 ng/mL), and the metabolites of DEHP (202 ng/mL), whereas samples from China and Japan contained the highest concentrations of miBP (50.8 ng/mL) and mMP (17.5 ng/mL), respectively. mEP was the predominant metabolite in urine samples from India and Kuwait (accounting for 49% of the total), mBP and miBP were the predominant compounds in samples from China (52%), and DEHP metabolites were the predominant compounds in samples from Korea (46%) and Vietnam (52%). Based on the urinary concentrations of mEP, mBP, miBP, and DEHP metabolites of the samples from the seven Asian countries, we estimated daily intake rates of diethyl phthalate (DEP), dibutyl phthalate (DBP), and DEHP. The results indicated that people in the seven Asian countries are exposed to DEP, DBP, and DEHP at levels well below the reference doses (RfD) suggested as unsafe by the U.S. Environmental Protection Agency (EPA). The estimated exposure doses to DEHP in Kuwait, however, were above the RfD recommended by the EPA.

Citing Articles

Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner.

Jadhao M, Hsu S, Deshmukh D, Liu P, Weng S, Chen Y Int J Biol Sci. 2025; 21(4):1705-1729.

PMID: 39990676 PMC: 11844279. DOI: 10.7150/ijbs.101598.


Combined BPA and DIBP Exposure Induced Intestinal Mucosal Barrier Impairment Through the Notch Pathway and Gut Microbiota Dysbiosis in Mice.

Duan M, Wang Y, Chen S, Lu J, Dong R, Yu Q Foods. 2025; 14(2).

PMID: 39856883 PMC: 11765467. DOI: 10.3390/foods14020214.


Prenatal Exposure to Dibutyl Phthalate and Its Negative Health Effects on Offspring: In Vivo and Epidemiological Studies.

Quelhas A, Mariana M, Cairrao E J Xenobiot. 2024; 14(4):2039-2075.

PMID: 39728417 PMC: 11677064. DOI: 10.3390/jox14040109.


Current Phthalate Exposure Risks of Rural Population in the Northwest China: Evidence from an Internal Exposure Study.

Zheng Y, Hua L, Zhang Z, Zhu L, Zhu H, Sun H Environ Health (Wash). 2024; 2(8):586-595.

PMID: 39474288 PMC: 11504103. DOI: 10.1021/envhealth.4c00057.


Association of Multiple Urinary Phthalates Metabolites with Diabetes Risk in Elderly Population.

Wang Y, Chen J, Shi J, Zhao Z, Chen J, Deng Y Environ Health (Wash). 2024; 2(3):140-149.

PMID: 39473819 PMC: 11504536. DOI: 10.1021/envhealth.3c00120.